OMGA / Omega Therapeutics, Inc. (NasdaqGS) - Forecast, Price Target, Estimates, Predictions. The 19 analysts offering price forecasts for Omega Therapeutics have a median target of , with a high estimate of and a low estimate of Week of September 3, NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends. View today's Omega Therapeutics Inc stock price and latest OMGA news and analysis. Create real-time notifications to follow any changes in the live stock. Find the latest analyst research, reports, and ratings for Omega Therapeutics, Inc. Common Stock (OMGA) at girlxinh.online
Omega Therapeutics Inc. ; Prev. Close. ; Low. ; 52wk Low. ; Market Cap. m ; Total Shares. m. Omega Therapeutics, Inc. is currently listed on NASDAQ under OMGA. One share of OMGA stock can currently be purchased for approximately $ OMGA | Complete Omega Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. How to buy OMGA stock on Public · Sign up for a brokerage account on Public · Add funds to your Public account · Choose how much you'd like to invest in OMGA. Stock analysis for Omega Therapeutics Inc (OMGA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. Omega Therapeutics is a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines. Investors Stock Quote & Chart · Stock Quote · Stock Chart · IR Contact · Email Alerts · Company · Science · Investors · Contact Us. [email protected] · OMGA Omega Therapeutics Inc · The ROS has soared by 71% YoY and by 33% from the previous quarter. The ROIC has soared by 67% YoY and by 16% from the previous. Omega Therapeutics Stock (NASDAQ: OMGA) stock price, news, charts, stock research, profile. Omega Therapeutics (OMGA) delivered earnings and revenue surprises of % and %, respectively, for the quarter ended June The 19 analysts offering price forecasts for Omega Therapeutics have a median target of , with a high estimate of and a low estimate of
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. OMEGA Therapeutics is a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines. Omega's stock is traded on the NASDAQ Global Select Market under the symbol OMGA. Omega's initial public offering (IPO) occurred in July Omega Therapeutics (OMGA) has a Smart Score of 4 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which is engaged in the development of a programmable epigenomic mRNA medicine. Discover real-time Omega Therapeutics, Inc. Common Stock (OMGA) stock prices, quotes, historical data, news, and Insights for informed trading and. Get the latest Omega Therapeutics Inc (OMGA) real-time quote, historical performance, charts, and other financial information to help you make more informed. Omega Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Omega Therapeutics' performance.
Research Omega Therapeutics' (Nasdaq:OMGA) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. Key Stats · Market CapM · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It. The average price target for Omega Therapeutics, Inc. comes to $ The forecasts range from a low of $ to a high of $ On average, Wall Street analysts predict that Omega Therapeutics's share price could reach $ by Aug 15, The average Omega Therapeutics stock price.
Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes. Omega Therapeutics shows weak development in a falling trend channel in the medium long term. Falling trends indicate that the company experiences negative. (NASDAQ: OMGA) Omega Therapeutics currently has 55,, outstanding shares. With Omega Therapeutics stock trading at $ per share, the total value of. Omega Therapeutics is a clinical-stage biotechnology company pioneering the development of a new class of programmable epigenomic mRNA medicines. Discover all the factors affecting Omega Therapeutics's share price. OMGA is currently rated as a Sucker Stock | Stockopedia. Get Omega Therapeutics Inc (OMGA) share price today, stock analysis, stock rating, price valuation, performance, fundamentals, market cap, shareholding.
Wlng Live | Best Science And Technology Funds